Bone Grafts and Substitutes Market Research Analysis Report and Clinical Outlook

Posted by Vedika on January 28th, 2021

The Global Bone Grafts and Substitutes Market size valued USD 2.96 billion in 2019, and is predicted to reach USD 4.85 billion by 2030, witnessing a CAGR of 4.5% from 2020-2030.

Bone grafting is a surgical procedure to operate extremely complicated bone fractures whereas bone grafts are implantable materials, used during the procedure to promote bone healing, bone formation, and osseous reconstruction. Depending on the grafting procedure, the bone grafts may be autologous, allograft or synthetic with mechanical properties replicating the bone. These grafts soon get reabsorbed and replaced with the healing of natural bone, and their efficacy depend on three basic principles viz. osteoconduction, osteoinduction, and osteogenesis. Bone grafts hold wide applications in spinal fusion, trauma, dental bone grafting, craniomaxillofacial, joint reconstruction and other bone grafting procedures.

Access Full Description of this report at:-

Top Companies: Johnson & Johnson, Arthrex, Inc., Baxter International Inc., Zimmer Biomet Holdings, Integra LifeSciences Holdings Corporation, Wright Medical Group N.V., Stryker Corporation, Musculoskeletal Transplant Foundation, NuVasive, Inc., Medtronic Plc., Inc. and others.

The bone grafts and substitutes market share analysis is based on type, application, end user, and geography. Based on type, the market is segmented into bone graft substitutes, allograft, and cell-based matrices. Based on application, the market covers spinal fusion, trauma, dental bone grafting, craniomaxillofacial, and joint reconstruction. Based on the type of material, the bone grafts and substitutes market is divided into collagen, hydroxyapatite, tricalcium phosphate, human cell source, animal source, and others. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

North America region is expected to dominate the global bone grafts and substitutes market throughout the forecast period, accounting for the highest market shares. This is attributed to factors such as well-established orthopedic specialty healthcare infrastructures, better reimbursement facility, higher adoption of advanced medical technologies, higher investments in R&D activities, and presence of key players in this region. It is expected that the emerging economies, specifically in the Asia-Pacific region shall witness increasing size of the bone grafts and substitutes market, owing to rapidly increasing geriatric population, growing adoption of bone grafts and substitutes in grafting modalities, as well as presence of large patient pool migrates in this region.

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Like it? Share it!


About the Author

Joined: November 28th, 2020
Articles Posted: 128

More by this author